FDA Seeks Comments on Evaluation of Proposed New Model for Reviewing BLAs

Published date28 June 2017
Law FirmGoodwin
Subject MatterFDA,Biologics,Comment Period,Pharmaceutical Industry,License Applications

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT